Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey
Anidulafungin has been shown to be non-inferior to, and possibly more efficacious, than fluconazole in treating patients with invasive candidiasis (IC). This study aimed to determine the cost-effectiveness of anidulafungin vs fluconazole for treatment of IC in the Turkish setting. A decision analyti...
| Published in: | Mycoses |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Blackwell Publishing Ltd
2017
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023160082&doi=10.1111%2fmyc.12651&partnerID=40&md5=16bbeb143ef3005883e393bae14d20d5 |